Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +1.43% | +0.71% | +5.97% |
24/04 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
25/03 | North American Morning Briefing : Tech in Focus on -2- | DJ |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
353M | - | - | ||||
546B | ||||||
359B | ||||||
323B | ||||||
290B | ||||||
234B |
- Stock Market
- Equities
- PGEN Stock
- Charts Precigen, Inc.
- Sector Chart